Cincinnati Bengals Screensaver

Our results corroborate time view that surfactant replacement therapy for ARDS might be enhanced by addition of SP-A.

SP-A + + and SP-A - - mice, respectively, compared Cincinnati corresponding control animals that were treated with saline Fig. By contrast, the Cincinnati Alteration type II sPLA 2 s, including IIC, IID, IIE, and IIF enzymes, were ineffective in hydrolysis. These data indicate that sPLA 2 -IIA is able to efficiently hydrolyze PG under life vivo conditions. We conclude that SP-A inhibits sPLA 2 had which may play a protective role by maintaining surfactant integrity during lung injury. Our findings support a potential role for SP-A that the protection of surfactant in the early phases of ARDS. Data are expressed as a percentage Alteration the control value and are the mean SEM of five independent experiments.

• Preparation of pulmonary surfactant Animals were killed Alteration Cincinnati i.
• Involvement animal granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis.
• SP-A too sPLA 2 -X activity, but fails to interfere with that of sPLA 2 -V.
• Proteins were transferred nitrocellulose membrane (Schleicher, Paris, France).
• McCormack for us the rabbit polyclonal anti-SP-A Ab, and C.

Furthermore, SP-A - - mice have no discernable abnormalities in surface activity or film stability even when lung injury is induced 29). The ratio of PC PG increased following the administration of sPLA 2 -IIA for SP-A - - Fig.

Alteration of surfactant phospholipids occurs very early during the of ARDS. Received for publication 13, 2003. PG hydrolysis by sPLA 2 asthmatic patients. It has also been shown that PG prevents the of the surfactant film (47). Inhibition of pulmonary function by phospholipases.

Intratracheal administration of sPLA 2 -IIA to mice causes hydrolysis surfactant phosphatidylglycerol. One hour after treatment, mice were killed by an overdose of pentobarbital. BALF was collected, and pulmonary was isolated as described above. Moreover, the of sPLA 2 to this receptor leads to an inhibition of catalytic activity (38). GIIA sPLA 2 (20 g) or an equivalent volume of saline was to anesthetized mice as indicated in Fig.

Moreover, in vitro inhibition of sPLA 2 -IIA-induces surfactant phospholipid hydrolysis correlates with the concentration of SP-A surfactant. View larger (45K): in this window in a new window FIGURE 3.

A role for A 2 in ARDS pathogenesis. In this study we tested in vitro their ability to hydrolyze surfactant phospholipids using surfactant from - - mice Fig. View version (18K): in this window in a new window FIGURE 5. The destruction of surfactant results in loss alveolar stability and severe deterioration of gas exchange, including alveolar collapse (2). On the diversity of secreted phospholipases 2 : cloning, tissue distribution, and functional expression of two novel mouse group II enzymes.

The respiratory distress syndrome. The separation of phospholipids was achieved by TLC using silica gel plates St. Cloning and recombinant expression a structurally novel human secreted phospholipase A 2. However, the type of sPLA involved in this disorder remains unclear. Acknowledgments We gratefully Dr.

A decrease in PG levels (by 80% in three these studies) and a moderate reduction of PC levels were observed. Therefore, it should be of great interest to know whether PG contributes to the pathophysiologic events encountered in ARDS. Pulmonary surfactant subfractions in patients with the acute respiratory syndrome. Expression of the type-II phospholipase A 2 alveolar macrophages: down-regulation by an inflammatory signal.

A rapid method of total lipid extraction purification. Taken together, these data support a role for sPLA 2 -IIA in the alterations in PG levels during the early phase of ARDS. All results are the SEM obtained from five animals.

• Surfactant chemical composition and biophysical activity in respiratory distress syndrome.
• This finding is consistent findings that sPLA 2 -IIA is 100-fold more active on anionic, rather than zwitterionic, phospholipids (9, 30).
• The increase in lung resistance was significantly higher in - - mice than in wild-type mice.
• While no change in PC levels was observed following treatment with sPLA -IIA, the PG content decreased significantly 13.

Effect sPlA 2 -IIA instillation on respiratory function of SP-A + + and SP-A - - mice. In contrast to PC, we observed a marked decrease in surfactant PG, in sPLA 2 -IIA-treated SP-A - - mice. B, Fatty acid release was measured after 1-h incubation of sPLA 2 -IIA with 2 mM surfactant phospholipids from mouse genotype.

The major function of surfactant is to the surface tension at the air-liquid interface of the alveolus.